Suppr超能文献

慢性粒细胞白血病:急性转化期的联合化疗

Chronic granulocytic leukaemia: multiple-drug chemotherapy for acute transformation.

作者信息

Spiers A D, Costello C, Catovsky D, Galton D A, Goldman J M

出版信息

Br Med J. 1974 Jul 13;3(5923):77-80. doi: 10.1136/bmj.3.5923.77.

Abstract

The response to 60 trials of therapy in 50 patients with chronic granulocytic leukaemia (C.G.L.) in acute transformation is reported. None of the 13 patients who received single-agent chemotherapy had a satisfactory response. The use of two drugs in combination produced only one satisfactory response in 30 patients. Various types of multiple-drug treatments in eight patients achieved one good response which lasted four months. In contrast when nine patients with rapidly progressive acute transformation of C.G.L. received a regimen-TRAMPCO(L)-incorporating seven or eight drugs (thioguanine, daunorubicin, cytarabine, methotrexate, prednisolone, cyclophosphamide, and vincristine, with or without L-asparaginase colaspase) five improved significantly. Four patients had a good clinical and haematological response with survival for over three, eight, over 12, and 14 and a half months; and one patient had a partial response. Toxicity was not extreme and maintenance therapy with the same regimen was given on an outpatient basis. TRAMPCO(L) seems superior to previously reported regimens and should be considered for rapidly progressive transformation of C.G.L. especially when simpler treatments have failed.

摘要

报告了50例慢性粒细胞白血病(C.G.L.)急性转化患者对60次治疗试验的反应。接受单药化疗的13例患者均无满意反应。30例患者联合使用两种药物仅产生1例满意反应。8例患者采用各种类型的多药治疗获得1例良好反应,持续了4个月。相比之下,9例C.G.L.快速进展急性转化患者接受包含7种或8种药物(硫鸟嘌呤、柔红霉素、阿糖胞苷、甲氨蝶呤、泼尼松龙、环磷酰胺和长春新碱,加或不加L-天冬酰胺酶 促胰酶)的TRAMPCO(L)方案治疗后,5例有显著改善。4例患者有良好的临床和血液学反应,生存期分别超过3个月、8个月、12个月和14个半月;1例患者有部分反应。毒性并不严重,门诊患者采用相同方案进行维持治疗。TRAMPCO(L)方案似乎优于先前报道的方案,对于C.G.L.的快速进展转化,尤其是在较简单治疗失败时,应考虑采用该方案。

相似文献

6
[Therapy of acute leukoses].[急性白血病的治疗]
Wien Med Wochenschr. 1973 Sep 22;123(38):549-54.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验